Low thyroid levels are a relatively common concern, and one form of this condition is due to an autoimmune disorder where the immune system attacks the thyroid gland causing a medical condition known as autoimmune thyroiditis. In this study, 15 patients diagnosed with this condition and who were on thyroid medication (levothryroxine), were evaluated from in a 2 week course of light therapy (consisting of only 10 sessions of light delivered bi-weekly). To objectively document the results, ultrasounds were performed before the light therapy, and then at 30 days following. Of more clinical relevance, ALL 15 PATIENTS who were evaluated after the conclusion of the study reduced their thyroid medication levels. What was even more astounding was that 7 of those 15 who participated in this study, did NOT require any at the nine month follow up  <view study > Read Less

Age-Related Macular Degeneration (AMD) is a main cause of vision loss in North America and is expected to impact our society considerably as our aging population grows. This publication clearly demonstrates the value of HBOT as 14 patients with advanced AMD made significant improvements in vision following hyperbaric oxygenation therapy <view study> Read Less

Some people still think that HBOT can be harmful by causing excessive oxidative and free radical disease. This study should finally put this controversy at rest. One of the main mechanisms of action in providing HBOT is the body’s compensation and ability to increase its Natural antioxidant defences. In return, the body is more geared at handling our current influx of stressors, including dietary and environmental chemicals. All studies have demonstrated an increase in anti-oxidant protection following HBOT and this study showed the genetic changes in antioxidant levels following HBOT. Here, the gene expressions were increased and thus a considerable elevation in our antioxidant defences. Understanding the role of free radical damage its positive correlation with accelerated aging and chronic disease states, preventative HBOT may hold a key in promoting healthy aging <view study> Read Less

The proliferation of cancer cells in this trial was reduced by the application of both HBOT and chemotherapy (5-FU). However, the combination of the 2 resulted in a marked and significant synergism in the reduction of cancer cell proliferation. HBOT’s role in this chemosensitization may be a powerful addition to current cancer practices <view study> Read Less

Read Less